The significantly different OS results of SKCM patients with different ages, sexes, tumor stages, T stages, N stages, M stages, TP53 expression, and wild-type TP53 levels between the high- and low-risk groups are shown in Figure 6, which demonstrates that the prognostic model was effective (p < 0.05). Here, TP53 is linked to neoplasm.